Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b

NCT00942591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Interferon beta 1b
DRUG: Atorvastatin

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]